OMERACT 7 psoriatic arthritis workshop: synopsis.
Outcome Measures in Rheumatology (OMERACT) conferences have developed a process by which outcome measures to be included in clinical trials are identified by consensus. During OMERACT 7, held in Asilomar, CA, USA, in May 2004, a workshop on outcome measures in psoriatic arthritis was held. Information derived through a previous Delphi exercise and nominal group process was shared with the participants, as were the results from a study using completed clinical trials with biological therapies. On the basis of the evidence presented and discussions in breakout groups at the OMERACT conference, a set of domains to be included in clinical trials in psoriatic arthritis was developed and a research agenda for further studies in psoriatic arthritis proposed.
Gladman
D D
DD
University of Toronto, Western Research Institute, Psoriatic Arthritis Program, Toronto Western Hospital, Ontario M5T 2S8, Canada. dafna.gladman@utoronto.ca
Strand
V
V
Mease
P J
PJ
Antoni
C
C
Nash
P
P
Kavanaugh
A
A
D015535:Arthritis, Psoriatic / Q000175:diagnosis* / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000379:methods; D006305:Health Status Indicators; D006801:Humans; D016896:Treatment Outcome